A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy - Song, J., Shi, J., Dong, D., Fang, M., Zhong, W., Wang, K., Wu, N., Huang, Y., Liu, Z., Cheng, Y., Gan, Y., Zhou, Y., Zhou, P., Chen, B., Liang, C., Liu, Z., Li, W., Tian, J. (The American Association for Cancer Research (AACR), 2018)
6312900
Keywords: WW-YZ